The association between p53 expression and prognosis for OS and CSS in patients with RCC were estimated, the results of pooled hazard ratio (HR) and 95% confidence interval (CI) are shown in Table 1 and Figure 2.Fifteen studies evaluated the relationship between p53 expression and OS in patients with RCC. The gene discussed is TP53; the disease is renal cell adenocarcinoma.